Add to ORKGBackground Barrett oesophagus (BO) occurs as a consequence of prolonged gastro-oesophageal reflux and it may precede the development of oesophageal adenocarcinoma. Aims The aim of this study was to accurately assess Cdx2 expression in the oesophageal metaplasiaedysplasiaeadenocarcinoma sequence. Method The expression of the transcription factor Cdx2 in Barrett metaplasia, high-grade glandular dysplasia and adenocarcinoma was investigated using immunohistochemistry. Results The results confirmed previous immunohistochemistry and PCR-based investigations, indicating that Cdx2was expressed by intestinalmetaplasi
CDX2 and liver-intestine (LI)-cadherin are intestine-specific markers and both are physiologically e...
International audienceBACKGROUND: CDX2 is a gene involved in the regulation of intestinal cell proli...
Background and aims Intestinal metaplasia (IM) is a gastric preneoplastic lesion that appears follow...
Background Barrett oesophagus (BO) occurs as a consequence of prolonged gastro-oesophageal reflux an...
textabstractBACKGROUND: In Barrett's oesophagus (BO), squamous epithelium is replaced by speci...
Background: Barrett’s mucosa is a risk factor for esophageal adenocarcinoma and should be detected a...
Abstract Background Barrett's mucosa is the precursor of esophageal adenocarcinoma. The molecular me...
Dysplasia in Barrett esophagus has been recognized to be morphologically heterogenous, featuring ade...
CDX2 is an intestinal transcription factor responsible for regulating the proliferation and differen...
Barrett’s esophagus (BE) is the replacement of the normal esophageal squamous epithelium by a column...
İstanbul Bilim Üniversitesi, Tıp Fakültesi.Objective: The description of Barrett's esophagus which i...
CDX2 is a recently cloned homeobox gene that encodes an intestine-specific transcription factor, exp...
Background: Barrett's mucosa is the precursor of esophageal adenocarcinoma. The molecular mecha...
Background and aims: CDX2 and Li-cadherin are intestinal specific markers that are normally only fou...
The molecular pathogenesis of Barrett's metaplasia (BM) of the esophagus is poorly understood. The c...
CDX2 and liver-intestine (LI)-cadherin are intestine-specific markers and both are physiologically e...
International audienceBACKGROUND: CDX2 is a gene involved in the regulation of intestinal cell proli...
Background and aims Intestinal metaplasia (IM) is a gastric preneoplastic lesion that appears follow...
Background Barrett oesophagus (BO) occurs as a consequence of prolonged gastro-oesophageal reflux an...
textabstractBACKGROUND: In Barrett's oesophagus (BO), squamous epithelium is replaced by speci...
Background: Barrett’s mucosa is a risk factor for esophageal adenocarcinoma and should be detected a...
Abstract Background Barrett's mucosa is the precursor of esophageal adenocarcinoma. The molecular me...
Dysplasia in Barrett esophagus has been recognized to be morphologically heterogenous, featuring ade...
CDX2 is an intestinal transcription factor responsible for regulating the proliferation and differen...
Barrett’s esophagus (BE) is the replacement of the normal esophageal squamous epithelium by a column...
İstanbul Bilim Üniversitesi, Tıp Fakültesi.Objective: The description of Barrett's esophagus which i...
CDX2 is a recently cloned homeobox gene that encodes an intestine-specific transcription factor, exp...
Background: Barrett's mucosa is the precursor of esophageal adenocarcinoma. The molecular mecha...
Background and aims: CDX2 and Li-cadherin are intestinal specific markers that are normally only fou...
The molecular pathogenesis of Barrett's metaplasia (BM) of the esophagus is poorly understood. The c...
CDX2 and liver-intestine (LI)-cadherin are intestine-specific markers and both are physiologically e...
International audienceBACKGROUND: CDX2 is a gene involved in the regulation of intestinal cell proli...
Background and aims Intestinal metaplasia (IM) is a gastric preneoplastic lesion that appears follow...